Drugs and Magic Remedies (Objectionable Advertisements) Act, 1955 MCQs With Answer

Introduction:
The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1955 was introduced to curb misleading and potentially harmful advertisements that promise miraculous cures for serious ailments. For M.Pharm students, understanding this Act is essential because it governs promotional practices, protects public health, and interfaces with drug regulation, ethics, and intellectual property concerns. This blog presents focused multiple-choice questions designed to deepen comprehension of the Act’s scope, definitions (such as “magic remedy” and “advertisement”), the schedule of prohibited claims, exemptions, liability of advertisers and publishers, and enforcement mechanisms. These MCQs emphasize applied legal knowledge useful for pharmacists, regulatory affairs professionals, and researchers.

Q1. What is the primary objective of the Drugs and Magic Remedies (Objectionable Advertisements) Act?

• To regulate drug manufacture standards
• To restrict and prohibit misleading advertisements that claim miraculous cures
• To control pricing of pharmaceutical products
• To license medical practitioners

Correct Answer: To restrict and prohibit misleading advertisements that claim miraculous cures

Q2. Under the Act, which of the following best describes a “magic remedy”?

• A device approved by regulators for surgical use
• An article or mode of treatment that claims miraculous or secret cure for listed diseases
• A cosmetic product for external use
• A vaccine developed using traditional methods

Correct Answer: An article or mode of treatment that claims miraculous or secret cure for listed diseases

Q3. Which type of message is covered by the Act’s definition of “advertisement”?

• Only print advertisements
• Any representation by whatever means including print, electronic, or visual media
• Internal company promotional memos only
• Government health advisories only

Correct Answer: Any representation by whatever means including print, electronic, or visual media

Q4. The Act contains a Schedule. What does this Schedule list?

• Manufacturers authorized under the Act
• Diseases, conditions and disorders for which advertisements are prohibited
• Approved marketing channels for medicinal products
• Fees payable for advertising approvals

Correct Answer: Diseases, conditions and disorders for which advertisements are prohibited

Q5. Which of the following claims would most likely be prohibited under the Act?

• Claim that a product relieves occasional headache
• Claim that a remedy can permanently cure cancer without evidence
• Statement of pharmacokinetic properties in a peer-reviewed journal
• Labeling of a vitamin tablet with dosage instructions

Correct Answer: Claim that a remedy can permanently cure cancer without evidence

Q6. Who can be held liable under the Act for a prohibited advertisement?

• Only the manufacturer of the product
• Advertisers, manufacturers, publishers and persons responsible for the advertisement
• Only the editor of a newspaper that carried the ad
• Only the retailer selling the product

Correct Answer: Advertisers, manufacturers, publishers and persons responsible for the advertisement

Q7. Which of the following is a typical enforcement action under the Act?

• License suspension for clinical trials
• Prosecution leading to penalties and seizure of objectionable material
• Mandatory product reformulation by law
• Automatic product recall without notice

Correct Answer: Prosecution leading to penalties and seizure of objectionable material

Q8. Are scientific and factual reports published in bona fide scientific journals generally covered by the prohibitions of the Act?

• No, bona fide scientific publications are generally exempt from the Act’s prohibitions
• Yes, all publications are always prohibited
• Only if the journal is published by a pharmaceutical company
• Only if the report is peer-reviewed

Correct Answer: No, bona fide scientific publications are generally exempt from the Act’s prohibitions

Q9. The Act is intended primarily to protect which of the following?

• Pharmaceutical company profits
• Public health and consumers from misleading claims
• Exclusive rights of traditional healers
• Export of drugs and cosmetics

Correct Answer: Public health and consumers from misleading claims

Q10. Which government level has the authority to make rules under the Act?

• Municipal corporations
• State governments only
• Central Government
• District collectors

Correct Answer: Central Government

Q11. An advertisement claims that a herbal product improves memory and prevents Alzheimer’s disease. Under the Act, this claim is:

• Permissible if the product is labeled as herbal
• Prohibited when it implies cure/prevention of a listed serious disease without proof
• Allowed only in local languages
• Exempt if sold in small quantities

Correct Answer: Prohibited when it implies cure/prevention of a listed serious disease without proof

Q12. Which of the following best describes the role of publishers under the Act?

• Publishers are never liable for third-party advertisements
• Publishers can be held responsible for carrying objectionable advertisements unless they demonstrate due diligence
• Publishers only need permission from advertisers to publish
• Publishers are only liable for digital ads

Correct Answer: Publishers can be held responsible for carrying objectionable advertisements unless they demonstrate due diligence

Q13. The Act applies to advertisements relating to which of the following?

• Only patented drugs
• Drugs, remedies and modes of treatment that claim to diagnose, cure, mitigate, treat or prevent listed conditions
• Only food products
• Only veterinary medicines

Correct Answer: Drugs, remedies and modes of treatment that claim to diagnose, cure, mitigate, treat or prevent listed conditions

Q14. If an advertisement only promotes nutritional benefits of a food without disease claims, how is it treated under the Act?

• Automatically considered objectionable
• Generally not covered unless it makes disease treatment/prevention claims included in the Schedule
• Requires pre-approval by the central authority
• Prohibited if the food is imported

Correct Answer: Generally not covered unless it makes disease treatment/prevention claims included in the Schedule

Q15. Which of the following statements about penalties under the Act is correct?

• Penalties are strictly limited to confiscation only
• Penalties may include prosecution leading to fines and/or imprisonment depending on the offence
• There are no penalties—only advisory notices
• Penalties include lifetime ban from manufacturing

Correct Answer: Penalties may include prosecution leading to fines and/or imprisonment depending on the offence

Q16. Does the Act cover claims made for animal health products?

• No, it only covers human medicines
• Yes, it can apply to remedies for animals if they make prohibited claims analogous to human conditions
• Only if sold in pharmacies
• Only for livestock vaccines

Correct Answer: Yes, it can apply to remedies for animals if they make prohibited claims analogous to human conditions

Q17. Which of the following is a practical compliance step companies should take to avoid contravention of the Act?

• Use exaggerated therapeutic claims to increase sales
• Ensure all promotional claims are evidence-based and do not refer to diseases listed in the Schedule
• Only advertise on social media
• Publish claims without documentation if marketed as traditional

Correct Answer: Ensure all promotional claims are evidence-based and do not refer to diseases listed in the Schedule

Q18. Which of the following types of claims would most likely be acceptable under the Act?

• Claim that a product “cures” a scheduled disease
• Factual description of composition and non-therapeutic benefits without disease claims
• Assertion of guaranteed permanent cure
• Claim offering money-back guarantee for a disease cure

Correct Answer: Factual description of composition and non-therapeutic benefits without disease claims

Q19. How should regulatory affairs professionals treat historical traditional claims in advertising under the Act?

• Republish traditional testimonials without evidence
• Refrain from making therapeutic claims about listed diseases unless supported by acceptable evidence and within regulatory allowances
• Claim superiority over modern medicines
• Rely solely on testimonials to substantiate claims

Correct Answer: Refrain from making therapeutic claims about listed diseases unless supported by acceptable evidence and within regulatory allowances

Q20. What is the value of studying the Drugs and Magic Remedies Act for M.Pharm students?

• Only academic interest with no practical application
• It equips graduates with knowledge to ensure ethical, legal and evidence-based promotion of therapeutics and to advise on regulatory compliance
• It solely helps in learning marketing tactics
• It replaces knowledge of pharmacology

Correct Answer: It equips graduates with knowledge to ensure ethical, legal and evidence-based promotion of therapeutics and to advise on regulatory compliance

Download